media

Markets

Market Nav

CASH FLOW

You can view the cash flow for the last 5 years.
Alembic Pharmaceuticals Ltd.
( in Crs.)

ParticularsMar 24Mar 23Mar 22Mar 21Mar 20
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue2.002.002.002.002.00
      
Net Profit/Loss Before Extraordinary Items And Tax632.81354.59620.111368.08999.82
      
Net CashFlow From Operating Activities803.20723.95552.361463.38449.13
Net Cash Used In Investing Activities-320.61-447.59-371.97-838.81-731.63
Net Cash Used From Financing Activities-437.87-261.96-217.36-597.42154.86
Foreign Exchange Gains / Losses0.000.000.00-0.930.41
      
Net Inc/Dec In Cash And Cash Equivalents44.7314.40-36.9726.22-127.23
Cash And Cash Equivalents Begin of Year75.4861.0898.0671.84199.07
Cash And Cash Equivalents End Of Year120.2175.4861.0998.0671.84
ParticularsMar 24
Months12
Source Of Info (AR = Annual Report, PR = Press Release)PR
FaceValue2.00
  
Net Profit/Loss Before Extraordinary Items And Tax632.81
Net CashFlow From Operating Activities803.20
Net Cash Used In Investing Activities-320.61
Net Cash Used From Financing Activities-437.87
Foreign Exchange Gains / Losses0.00
Net Inc/Dec In Cash And Cash Equivalents44.73
Cash And Cash Equivalents Begin of Year75.48
Cash And Cash Equivalents End Of Year120.21